SNWV

#4342
SANUWAVE Health, Inc. - Common Stock
4.6 3 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.62
4.63
Intervallo Annuale
4.50
25.62
Variazione giornaliera
-1.28%
Variazione Mensile
-24.96%
Variazione di 6 mesi
-80.71%
Variazione Annuale
-80.84%
Chiusura Precedente
4.6 9
Open
4.6 2
Minimo
4.6 2
Massimo
4.6 3
Volume
2
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SANUWAVE Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SANUWAVE Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K

SANUWAVE Health, Inc. current report, Q2 FY2026

Full document

Business Context and Reporting Period

This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by SANUWAVE Health, Inc. on June 11, 2026. The filing details the voting results for three proposals submitted to security holders.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.

Material Changes and Voting Results

The following matters were voted upon by stockholders:

  • Proposal 1: Election of Directors
    • All five nominees were elected to serve until the 2027 annual meeting.
    • Morgan Frank: 4,988,463 votes For; 69,863 Withheld.
    • Gregory Bazar: 4,706,567 votes For; 351,759 Withheld.
    • Jeffrey Blizard: 4,634,031 votes For; 424,295 Withheld.
    • Ian Miller: 4,244,965 votes For; 813,361 Withheld.
    • James Tyler: 4,292,161 votes For; 766,165 Withheld.
    • Broker Non-Votes: 1,061,530 for all nominees.
  • Proposal 2: Ratification of Auditors
    • Baker Tilly US, LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
    • Results: 6,057,957 For; 45,261 Against; 16,638 Abstain.
  • Proposal 3: Executive Compensation (Say-on-Pay)
    • Advisory, non-binding vote to approve compensation for named executive officers.
    • Results: 4,666,444 For; 385,238 Against; 6,644 Abstain.
    • Broker Non-Votes: 1,061,530.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.

Investor Verification Checklist

  • Verify the tenure of the newly elected directors (Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller, James Tyler) through the 2027 annual meeting.
  • Confirm the appointment of Baker Tilly US, LLP as the auditor for the fiscal year ending December 31, 2026.
  • Note the significant number of broker non-votes (1,061,530) on director elections and the say-on-pay proposal, indicating shares held in street name where brokers lacked discretionary voting power.
  • Review the "Votes Against" and "Withheld" counts for directors Ian Miller and James Tyler, which were notably higher than for other nominees.